Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Pharma Consultancy in Hyderabad in 2026: GMP Audits, Validation and Inspection Readiness

Pharmaceutical manufacturers in Hyderabad face rising expectations for quality, documentation, and regulatory compliance. Explore how expert consulting support can address revised Schedule M requirements, identify GMP gaps, and improve audit preparation, validation, and long-term operational readiness.
  • Blog, Quality Management System
Pharmaceutical quality professionals reviewing production records in a cleanroom, illustrating GMP gap assessment and manufacturing quality oversight in Hyderabad.

Pharma Consultancy in Kolkata in 2026: GMP Compliance and Inspection Readiness

Preparing for a GMP inspection takes more than updated documents. Discover how pharma consultancy in Kolkata helps manufacturers address compliance gaps, strengthen quality systems, meet revised Schedule M requirements, and build reliable evidence for CDSCO inspections.
  • Blog, Quality Management System
Two pharmaceutical quality specialists reviewing manufacturing documentation during a GMP gap assessment, with Kolkata's Howrah Bridge in the background.

Pharma Consultants in Ahmedabad in 2026: GMP, Regulatory & Validation Services

Explore how pharmaceutical consultancy services in Ahmedabad support Schedule M compliance, GMP systems, validation, CDSCO readiness, plant projects, and inspection preparation. Learn what to verify before hiring a specialist and how to match expertise with project risk.
  • Blog, Quality Management System
Pharmaceutical manufacturing specialists reviewing GMP compliance, Schedule M requirements, validation records, and quality systems inside a modern production facility.

Pharma Regulatory Consultants in 2026: Regulatory Strategy, EMA, FDA & MHRA Support

Explore how regulatory strategy, eCTD submissions, health authority interactions, and lifecycle management shape successful pharmaceutical development. This article explains when external expertise adds value, how to choose the right consulting partner, and where stronger planning can reduce regulatory risk.
  • Blog, Quality Management System
Pharmaceutical regulatory affairs services supporting eCTD submissions, health authority interactions, and lifecycle management.

Post-Market Surveillance of Medical Devices in 2026: EU MDR, PMS Plans, PSUR & Vigilance Requirements Public Health

Learn how EU MDR requirements shape PMS plans, PSURs, PMCF, vigilance, trend reporting, and risk management across device classes. This guide explains practical reporting duties, evidence flows, and regulatory controls that help manufacturers maintain compliant, inspection-ready post-market systems.
  • Blog, Medical Devices
Medical device vigilance workflow showing risk management, trend reporting, and regulatory monitoring under EU MDR.

Pharmacovigilance Training in 2026: Courses, GVP Skills, and Certification

Strong pharmacovigilance programs build more than regulatory knowledge. This guide explains how to compare courses, develop GVP skills, strengthen inspection readiness, document competence, and connect training with real drug safety responsibilities across regulated pharmaceutical environments.
  • Blog, GMP
Pharmaceutical professional reviewing adverse event reporting, ICSR processing, signal detection, and compliance data on a digital interface.

Pharmacovigilance Specialist in 2026: Job Description, Skills, and Career Path

Explore what a drug safety role involves, from ICSR processing and MedDRA coding to signal detection, GVP compliance, and career development. Learn which skills employers expect, how responsibilities support inspection readiness, and how professionals can enter the field.
  • Blog, Quality Management System
Drug-Safety-Spezialist bei der Prüfung von Falldaten und Dashboards zur Signalerkennung in einem modernen pharmazeutischen Arbeitsumfeld.

Patient Safety Importance in 2026: How GMP Compliance and Quality Risk Management Protect Patients

Explore how GMP compliance, quality risk management, CAPA, data integrity, and contamination control connect manufacturing decisions to patient protection. This article explains what inspectors look for, which evidence matters, and how strong quality systems reduce pharmaceutical risk.
  • Blog, Quality Management System
Pharmazeutische Produktionsanlage mit GMP-Compliance, Datenintegrität, Kontaminationskontrolle und Qualitätsrisikomanagement in einer modernen Herstellungsumgebung.

Pharmacovigilance Consultants in 2026: Services, Compliance and Inspection Readiness

Pharmaceutical companies face growing pressure to keep pharmacovigilance systems inspection-ready while managing outsourcing, quality gaps, and complex regulatory requirements. This article explains where external expertise adds value, how to evaluate support, and which controls matter most for sustainable compliance.
  • Blog, Quality Management System
Pharmazeutische Fachkräfte prüfen Arzneimittelsicherheitsdaten, Qualitätskontrollen und die Inspektionsbereitschaft in der Pharmakovigilanz in einem regulierten Umfeld.

Data Safety Monitoring in Pharma in 2026: DSMB Oversight Risk Signals and Trial Decisions

Explore how DSMBs review safety signals, assess benefit risk, manage interim analyses, and document trial decisions. This guide explains the evidence, controls, and inspection-ready records pharmaceutical teams need to strengthen clinical trial oversight and support regulatory compliance
  • Blog, Quality Management System
Data Monitoring Committee bei der Prüfung von Sicherheitszwischendaten, Nutzen-Risiko-Bewertung und Überwachung klinischer Studien in einem pharmazeutischen Umfeld.